Global Gabapentin Market Research Report 2021

Publisher Name :
Date: 17-Feb-2021
No. of pages: 120
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Capsule

- Tablet

Segment by Application

- Epilepsy

- Neuropathic Pain

- Restless Legs Syndrome

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Pfizer

- Assertio Therapeutics

- TEVA

- Mylan

- Arbor Pharma

- Novartis

- Apotex

- Sun Pharmaceutical

- Aurobindo Pharma

- Intas

- Amneal

- Marksans Pharma

- Glenmark

- Alkem

- Jiangsu Enhua

- Jiangsu Hengrui

- Sailike

Global Gabapentin Market Research Report 2021

Table of Contents
1 Gabapentin Market Overview
1.1 Product Overview and Scope of Gabapentin
1.2 Gabapentin Segment by Type
1.2.1 Global Gabapentin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Capsule
1.2.3 Tablet
1.3 Gabapentin Segment by Application
1.3.1 Gabapentin Sales Comparison by Application: (2021-2027)
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Global Gabapentin Market Size Estimates and Forecasts
1.4.1 Global Gabapentin Revenue 2016-2027
1.4.2 Global Gabapentin Sales 2016-2027
1.4.3 Gabapentin Market Size by Region: 2016 Versus 2021 Versus 2027
2 Gabapentin Market Competition by Manufacturers
2.1 Global Gabapentin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Gabapentin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Gabapentin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Gabapentin Manufacturing Sites, Area Served, Product Type
2.5 Gabapentin Market Competitive Situation and Trends
2.5.1 Gabapentin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gabapentin Players Market Share by Revenue
2.5.3 Global Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gabapentin Retrospective Market Scenario by Region
3.1 Global Gabapentin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Gabapentin Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Gabapentin Market Facts & Figures by Country
3.3.1 North America Gabapentin Sales by Country
3.3.2 North America Gabapentin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Gabapentin Market Facts & Figures by Country
3.4.1 Europe Gabapentin Sales by Country
3.4.2 Europe Gabapentin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gabapentin Market Facts & Figures by Region
3.5.1 Asia Pacific Gabapentin Sales by Region
3.5.2 Asia Pacific Gabapentin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Gabapentin Market Facts & Figures by Country
3.6.1 Latin America Gabapentin Sales by Country
3.6.2 Latin America Gabapentin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gabapentin Market Facts & Figures by Country
3.7.1 Middle East and Africa Gabapentin Sales by Country
3.7.2 Middle East and Africa Gabapentin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Gabapentin Historic Market Analysis by Type
4.1 Global Gabapentin Sales Market Share by Type (2016-2021)
4.2 Global Gabapentin Revenue Market Share by Type (2016-2021)
4.3 Global Gabapentin Price by Type (2016-2021)
5 Global Gabapentin Historic Market Analysis by Application
5.1 Global Gabapentin Sales Market Share by Application (2016-2021)
5.2 Global Gabapentin Revenue Market Share by Application (2016-2021)
5.3 Global Gabapentin Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Assertio Therapeutics
6.2.1 Assertio Therapeutics Corporation Information
6.2.2 Assertio Therapeutics Description and Business Overview
6.2.3 Assertio Therapeutics Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Assertio Therapeutics Product Portfolio
6.2.5 Assertio Therapeutics Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 TEVA Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Arbor Pharma
6.5.1 Arbor Pharma Corporation Information
6.5.2 Arbor Pharma Description and Business Overview
6.5.3 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Arbor Pharma Product Portfolio
6.5.5 Arbor Pharma Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novartis Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Apotex Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporation Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sun Pharmaceutical Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Corporation Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Aurobindo Pharma Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 Intas
6.10.1 Intas Corporation Information
6.10.2 Intas Description and Business Overview
6.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Intas Product Portfolio
6.10.5 Intas Recent Developments/Updates
6.11 Amneal
6.11.1 Amneal Corporation Information
6.11.2 Amneal Gabapentin Description and Business Overview
6.11.3 Amneal Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Amneal Product Portfolio
6.11.5 Amneal Recent Developments/Updates
6.12 Marksans Pharma
6.12.1 Marksans Pharma Corporation Information
6.12.2 Marksans Pharma Gabapentin Description and Business Overview
6.12.3 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Marksans Pharma Product Portfolio
6.12.5 Marksans Pharma Recent Developments/Updates
6.13 Glenmark
6.13.1 Glenmark Corporation Information
6.13.2 Glenmark Gabapentin Description and Business Overview
6.13.3 Glenmark Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Glenmark Product Portfolio
6.13.5 Glenmark Recent Developments/Updates
6.14 Alkem
6.14.1 Alkem Corporation Information
6.14.2 Alkem Gabapentin Description and Business Overview
6.14.3 Alkem Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Alkem Product Portfolio
6.14.5 Alkem Recent Developments/Updates
6.15 Jiangsu Enhua
6.15.1 Jiangsu Enhua Corporation Information
6.15.2 Jiangsu Enhua Gabapentin Description and Business Overview
6.15.3 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Jiangsu Enhua Product Portfolio
6.15.5 Jiangsu Enhua Recent Developments/Updates
6.16 Jiangsu Hengrui
6.16.1 Jiangsu Hengrui Corporation Information
6.16.2 Jiangsu Hengrui Gabapentin Description and Business Overview
6.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Jiangsu Hengrui Product Portfolio
6.16.5 Jiangsu Hengrui Recent Developments/Updates
6.17 Sailike
6.17.1 Sailike Corporation Information
6.17.2 Sailike Gabapentin Description and Business Overview
6.17.3 Sailike Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Sailike Product Portfolio
6.17.5 Sailike Recent Developments/Updates
7 Gabapentin Manufacturing Cost Analysis
7.1 Gabapentin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gabapentin
7.4 Gabapentin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gabapentin Distributors List
8.3 Gabapentin Customers
9 Gabapentin Market Dynamics
9.1 Gabapentin Industry Trends
9.2 Gabapentin Growth Drivers
9.3 Gabapentin Market Challenges
9.4 Gabapentin Market Restraints
10 Global Market Forecast
10.1 Gabapentin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gabapentin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Gabapentin by Type (2022-2027)
10.2 Gabapentin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gabapentin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Gabapentin by Application (2022-2027)
10.3 Gabapentin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gabapentin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Gabapentin by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Gabapentin Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Gabapentin Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Gabapentin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Gabapentin Covered in This Study
Table 5. Global Gabapentin Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Gabapentin Sales Share by Manufacturers (2016-2021)
Table 7. Global Gabapentin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Gabapentin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Gabapentin Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Gabapentin Manufacturing Sites and Area Served
Table 11. Manufacturers Gabapentin Product Type
Table 12. Global Gabapentin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Gabapentin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gabapentin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Gabapentin Sales by Region (2016-2021) & (K MT)
Table 16. Global Gabapentin Sales Market Share by Region (2016-2021)
Table 17. Global Gabapentin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Gabapentin Sales by Country (2016-2021) & (K MT)
Table 19. North America Gabapentin Sales Market Share by Country (2016-2021)
Table 20. North America Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Gabapentin Revenue Market Share by Country (2016-2021)
Table 22. Europe Gabapentin Sales by Country (2016-2021) & (K MT)
Table 23. Europe Gabapentin Sales Market Share by Country (2016-2021)
Table 24. Europe Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Gabapentin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Gabapentin Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Gabapentin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Gabapentin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Gabapentin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Gabapentin Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Gabapentin Sales Market Share by Country (2016-2021)
Table 32. Latin America Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Gabapentin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Gabapentin Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Gabapentin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Gabapentin Revenue Market Share by Country (2016-2021)
Table 38. Global Gabapentin Sales (K MT) by Type (2016-2021)
Table 39. Global Gabapentin Sales Market Share by Type (2016-2021)
Table 40. Global Gabapentin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Gabapentin Revenue Share by Type (2016-2021)
Table 42. Global Gabapentin Price (USD/MT) by Type (2016-2021)
Table 43. Global Gabapentin Sales (K MT) by Application (2016-2021)
Table 44. Global Gabapentin Sales Market Share by Application (2016-2021)
Table 45. Global Gabapentin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Gabapentin Revenue Share by Application (2016-2021)
Table 47. Global Gabapentin Price (USD/MT) by Application (2016-2021)
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Pfizer Gabapentin Product
Table 52. Pfizer Recent Developments/Updates
Table 53. Assertio Therapeutics Corporation Information
Table 54. Assertio Therapeutics Description and Business Overview
Table 55. Assertio Therapeutics Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Assertio Therapeutics Gabapentin Product
Table 57. Assertio Therapeutics Recent Developments/Updates
Table 58. TEVA Corporation Information
Table 59. TEVA Description and Business Overview
Table 60. TEVA Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. TEVA Gabapentin Product
Table 62. TEVA Recent Developments/Updates
Table 63. Mylan Corporation Information
Table 64. Mylan Description and Business Overview
Table 65. Mylan Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Mylan Gabapentin Product
Table 67. Mylan Recent Developments/Updates
Table 68. Arbor Pharma Corporation Information
Table 69. Arbor Pharma Description and Business Overview
Table 70. Arbor Pharma Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Arbor Pharma Gabapentin Product
Table 72. Arbor Pharma Recent Developments/Updates
Table 73. Novartis Corporation Information
Table 74. Novartis Description and Business Overview
Table 75. Novartis Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Novartis Gabapentin Product
Table 77. Novartis Recent Developments/Updates
Table 78. Apotex Corporation Information
Table 79. Apotex Description and Business Overview
Table 80. Apotex Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Apotex Gabapentin Product
Table 82. Apotex Recent Developments/Updates
Table 83. Sun Pharmaceutical Corporation Information
Table 84. Sun Pharmaceutical Description and Business Overview
Table 85. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Sun Pharmaceutical Gabapentin Product
Table 87. Sun Pharmaceutical Recent Developments/Updates
Table 88. Aurobindo Pharma Corporation Information
Table 89. Aurobindo Pharma Description and Business Overview
Table 90. Aurobindo Pharma Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Aurobindo Pharma Gabapentin Product
Table 92. Aurobindo Pharma Recent Developments/Updates
Table 93. Intas Corporation Information
Table 94. Intas Description and Business Overview
Table 95. Intas Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Intas Gabapentin Product
Table 97. Intas Recent Developments/Updates
Table 98. Amneal Corporation Information
Table 99. Amneal Description and Business Overview
Table 100. Amneal Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Amneal Gabapentin Product
Table 102. Amneal Recent Developments/Updates
Table 103. Marksans Pharma Corporation Information
Table 104. Marksans Pharma Description and Business Overview
Table 105. Marksans Pharma Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Marksans Pharma Gabapentin Product
Table 107. Marksans Pharma Recent Developments/Updates
Table 108. Glenmark Corporation Information
Table 109. Glenmark Description and Business Overview
Table 110. Glenmark Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. Glenmark Gabapentin Product
Table 112. Glenmark Recent Developments/Updates
Table 113. Alkem Corporation Information
Table 114. Alkem Description and Business Overview
Table 115. Alkem Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Alkem Gabapentin Product
Table 117. Alkem Recent Developments/Updates
Table 118. Jiangsu Enhua Corporation Information
Table 119. Jiangsu Enhua Description and Business Overview
Table 120. Jiangsu Enhua Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Jiangsu Enhua Gabapentin Product
Table 122. Jiangsu Enhua Recent Developments/Updates
Table 123. Jiangsu Hengrui Corporation Information
Table 124. Jiangsu Hengrui Description and Business Overview
Table 125. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 126. Jiangsu Hengrui Gabapentin Product
Table 127. Jiangsu Hengrui Recent Developments/Updates
Table 128. Sailike Corporation Information
Table 129. Sailike Description and Business Overview
Table 130. Sailike Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 131. Sailike Gabapentin Product
Table 132. Sailike Recent Developments/Updates
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Gabapentin Distributors List
Table 136. Gabapentin Customers List
Table 137. Gabapentin Market Trends
Table 138. Gabapentin Growth Drivers
Table 139. Gabapentin Market Restraints
Table 140. Global Gabapentin Sales Forecast by Type (2022-2027) & (K MT)
Table 141. Global Gabapentin Sales Market Share Forecast by Type (2022-2027)
Table 142. Global Gabapentin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 143. Global Gabapentin Revenue Market Share Forecast by Type (2022-2027)
Table 144. Global Gabapentin Sales Forecast by Application (2022-2027) & (K MT)
Table 145. Global Gabapentin Sales Market Share Forecast by Application (2022-2027)
Table 146. Global Gabapentin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 147. Global Gabapentin Revenue Market Share Forecast by Application (2022-2027)
Table 148. Global Gabapentin Sales Forecast by Region (2022-2027) & (K MT)
Table 149. Global Gabapentin Sales Market Share Forecast by Region (2022-2027)
Table 150. Global Gabapentin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 151. Global Gabapentin Revenue Market Share Forecast by Region (2022-2027)
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gabapentin
Figure 2. Global Gabapentin Market Share by Type in 2020 & 2027
Figure 3. Capsule Product Picture
Figure 4. Tablet Product Picture
Figure 5. Global Gabapentin Market Share by Application in 2020 & 2027
Figure 6. Epilepsy
Figure 7. Neuropathic Pain
Figure 8. Restless Legs Syndrome
Figure 9. Others
Figure 10. Global Gabapentin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Gabapentin Market Size 2016-2027 (US$ Million)
Figure 12. Global Gabapentin Sales 2016-2027 (K MT)
Figure 13. Global Gabapentin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Gabapentin Sales Share by Manufacturers in 2020
Figure 15. Global Gabapentin Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Gabapentin Players: Market Share by Revenue in 2020
Figure 17. Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Gabapentin Sales Market Share by Region (2016-2021)
Figure 19. Global Gabapentin Sales Market Share by Region in 2020
Figure 20. Global Gabapentin Revenue Market Share by Region (2016-2021)
Figure 21. Global Gabapentin Revenue Market Share by Region in 2020
Figure 22. U.S. Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Gabapentin by Type (2016-2021)
Figure 47. Sales Market Share of Gabapentin by Application (2016-2021)
Figure 48. Sales Market Share of Gabapentin by Application in 2020
Figure 49. Revenue Share of Gabapentin by Application (2016-2021)
Figure 50. Revenue Share of Gabapentin by Application in 2020
Figure 51. Manufacturing Cost Structure of Gabapentin
Figure 52. Manufacturing Process Analysis of Gabapentin
Figure 53. Gabapentin Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
  • Global Autism Spectrum Disorder Market Growth (Status and Outlook) 2021-2026
    Published: 17-Mar-2021        Price: US 3660 Onwards        Pages: 117
    According to this latest study, the 2021 growth of Autism Spectrum Disorder will have significant change from previous year. By the most conservative estimates of global Autism Spectrum Disorder market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 384400 million in 2020. Over the next five years the Autism Spectrum Disorder market will register a 17.9% CAGR in terms of revenue, the global market size will reach US$ 743920 million by 2026. ......
  • Global Gabapentin Market Growth 2021-2026
    Published: 16-Mar-2021        Price: US 3660 Onwards        Pages: 159
    According to this latest study, the 2021 growth of Gabapentin will have significant change from previous year. By the most conservative estimates of global Gabapentin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1482.5 million in 2020. Over the next five years the Gabapentin market will register a 1.9% CAGR in terms of revenue, the global market size will reach US$ 1596.4 million by 2026. This report presents a comprehensi......
  • Global Restless Legs Syndrome Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 16-Mar-2021        Price: US 3500 Onwards        Pages: 116
    Based on the Restless Legs Syndrome market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analy......
  • Global Gabapentin Market Research Report 2021
    Published: 17-Feb-2021        Price: US 2900 Onwards        Pages: 120
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Capsule - Tablet Segment by Application - Epilepsy - Neuropathic Pain - Restle......
  • Global Gabapentin Market Analysis 2016-2020 and Forecast 2021-2026
    Published: 13-Feb-2021        Price: US 2980 Onwards        Pages: 85
    Snapshot Gabapentin is an anti-epileptic medication, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain. The global Gabapentin market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then ana......
  • Global Biopolar Disorder Therapeutics Market Research Report 2021
    Published: 10-Feb-2021        Price: US 2900 Onwards        Pages: 92
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Mood Stabilizers - Antipsychotic Drugs - Antidepressant Drugs - Others Segment by App......
  • Chronic inflammatory demyelinating polyneuropathy (CIDP) - Pipeline Insight, 2021
    Published: 10-Feb-2021        Price: US 1500 Onwards        Pages: 60
    DelveInsight's, "Chronic inflammatory demyelinating polyneuropathy (CIDP) - Pipeline Insight, 2021," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Chronic inflammatory demyelinating polyneuropathy (CIDP) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pi......
  • Chronic Traumatic Encephalopathy - Pipeline Insight, 2021
    Published: 10-Feb-2021        Price: US 1500 Onwards        Pages: 60
    DelveInsight's, "Chronic Traumatic Encephalopathy - Pipeline Insight, 2021," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Chronic traumatic encephalopathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geogra......
  • Small Fiber Neuropathy - Pipeline Insight, 2021
    Published: 10-Feb-2021        Price: US 1500 Onwards        Pages: 60
    DelveInsight's, "Small Fiber Neuropathy - Pipeline Insight, 2021," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Small Fiber Neuropathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs